RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCI SCIE SCOPUS

      Bidirectional Association between First-Episode Panic Disorder and Major Depressive Disorder in a Nationwide General Population Survey in Korea

      한글로보기

      https://www.riss.kr/link?id=A106279091

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background: Panic disorder (PD) and major depressive disorder (MDD) can occur concurrently, despite different clinical manifestations. Because MDD and PD patients tend to have more complicated conditions, understanding the co-occurrence and pattern of...

      Background: Panic disorder (PD) and major depressive disorder (MDD) can occur concurrently, despite different clinical manifestations. Because MDD and PD patients tend to have more complicated conditions, understanding the co-occurrence and pattern of these conditions is important. Here, we investigated the influence of PD and MDD on each other, with respect to time interval.
      Methods: Data from three national representative surveys were pooled (total 18,807 respondents), and the age of onset (AOO) of PD and MDD was analyzed. We performed Kaplan-Meier analysis to estimate separate survival functions, using the AOO of MDD and PD as the outcome. To understand the temporal effect of other disorders, we used a Cox proportional hazard model to estimate the hazard ratios for the onset of MDD/PD with other comorbidities as time-dependent covariates.
      Results: PD elevated the risk of subsequent MDD by 1.5-fold, whereas MDD elevated the risk of subsequent PD by 3.8-fold. The effect of such an elevation risk was significant for up to 2 years.
      Conclusion: The results revealed a bidirectional relationship between MDD and PD.
      Each disease represents a risk of a subsequent occurrence of the other, which lasts for a considerable duration.

      더보기

      참고문헌 (Reference)

      1 조맹제, "한국어판 Composite International Diagnostic Interview(K-CIDI)의 개발" 대한신경정신의학회 41 (41): 2002

      2 Brown C, "Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders" 153 (153): 1293-1300, 1996

      3 Gimeno C, "Treatment of comorbid alcohol dependence and anxiety disorder : review of the scientific evidence and recommendations for treatment" 8 : 173-, 2017

      4 Barrera TL, "The experience of panic symptoms across racial groups in a student sample" 24 (24): 873-878, 2010

      5 Hirschfeld RM, "The comorbidity of major depression and anxiety disorders : recognition and management in primary care" 3 (3): 244-254, 2001

      6 Clayton PJ, "The comorbidity factor: establishing the primary diagnosis in patients with mixed symptoms of anxiety and depression" 51 (51): 35-39, 1990

      7 Wittchen HU, "Recall and dating of psychiatric symptoms. Test-retest reliability of time-related symptom questions in a standardized psychiatric interview" 46 (46): 437-443, 1989

      8 Dunlop DD, "Racial/ethnic differences in rates of depression among preretirement adults" 93 (93): 1945-1952, 2003

      9 Eaton WW, "Psychopathology and attrition in the epidemiologic catchment area surveys" 135 (135): 1051-1059, 1992

      10 Cox BJ, "Psychological vulnerabilities in patients with major depression vs panic disorder" 39 (39): 567-573, 2001

      1 조맹제, "한국어판 Composite International Diagnostic Interview(K-CIDI)의 개발" 대한신경정신의학회 41 (41): 2002

      2 Brown C, "Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders" 153 (153): 1293-1300, 1996

      3 Gimeno C, "Treatment of comorbid alcohol dependence and anxiety disorder : review of the scientific evidence and recommendations for treatment" 8 : 173-, 2017

      4 Barrera TL, "The experience of panic symptoms across racial groups in a student sample" 24 (24): 873-878, 2010

      5 Hirschfeld RM, "The comorbidity of major depression and anxiety disorders : recognition and management in primary care" 3 (3): 244-254, 2001

      6 Clayton PJ, "The comorbidity factor: establishing the primary diagnosis in patients with mixed symptoms of anxiety and depression" 51 (51): 35-39, 1990

      7 Wittchen HU, "Recall and dating of psychiatric symptoms. Test-retest reliability of time-related symptom questions in a standardized psychiatric interview" 46 (46): 437-443, 1989

      8 Dunlop DD, "Racial/ethnic differences in rates of depression among preretirement adults" 93 (93): 1945-1952, 2003

      9 Eaton WW, "Psychopathology and attrition in the epidemiologic catchment area surveys" 135 (135): 1051-1059, 1992

      10 Cox BJ, "Psychological vulnerabilities in patients with major depression vs panic disorder" 39 (39): 567-573, 2001

      11 de Graaf R, "Psychiatric and sociodemographic predictors of attrition in a longitudinal study: the Netherlands Mental Health Survey and Incidence Study (NEMESIS)" 152 (152): 1039-1047, 2000

      12 World Health Organization, "Procedures for the Development of New Language Versions of the WHO Composite International Diagnostic Interview (WHO-CIDI) Geneva"

      13 Alonso J, "Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project" (420) : 21-27, 2004

      14 Cho MJ, "Prevalence of DSM-IV major mental disorders among Korean adults: a 2006 National Epidemiologic Survey (KECA-R)" 3 (3): 26-30, 2010

      15 조맹제, "Prevalence and Correlates of DSM-IV Mental Disorders in South Korean Adults: The Korean Epidemiologic Catchment Area Study 2011" 대한신경정신의학회 12 (12): 164-170, 2015

      16 Brown C, "Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice" 2 (2): 210-218, 1996

      17 Tilli V, "Panic disorder in primary care : comorbid psychiatric disorders and their persistence" 30 (30): 247-253, 2012

      18 Stein MB, "Panic disorder and major depression. A tale of two syndromes" 11 (11): 441-461, 1988

      19 Simon NM, "Panic disorder and bipolar disorder : anxiety sensitivity as a potential mediator of panic during manic states" 87 (87): 101-105, 2005

      20 Noyes R, "Outcome of panic disorder. Relationship to diagnostic subtypes and comorbidity" 47 (47): 809-818, 1990

      21 Dolan RJ, "Neuropsychological dysfunction in depression : the relationship to regional cerebral blood flow" 24 (24): 849-857, 1994

      22 Kessler RC, "Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication" 62 (62): 593-602, 2005

      23 Roy-Byrne PP, "Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking" 176 (176): 229-235, 2000

      24 Kessler RC, "Lifetime panic-depression comorbidity in the National Comorbidity Survey" 55 (55): 801-808, 1998

      25 Cho MJ, "Lifetime and 12-month prevalence of DSM-IV psychiatric disorders among Korean adults" 195 (195): 203-210, 2007

      26 Keller MB, "Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo" 28 (28): 27-38, 1993

      27 Lawson C, "Depression and the interpretation of ambiguity" 37 (37): 463-474, 1999

      28 Pirkola SP, "DSM-IV mood-, anxiety-and alcohol use disorders and their comorbidity in the Finnish general population--results from the Health 2000 Study" 40 (40): 1-10, 2005

      29 Chang SM, "Cross-national difference in the prevalence of depression caused by the diagnostic threshold" 106 (106): 159-167, 2008

      30 Roy-Byrne PP, "Coping in panic and major depressive disorder. Relative effects of symptom severity and diagnostic comorbidity" 180 (180): 179-183, 1992

      31 Merikangas KR, "Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse : results of an international task force" 168 (168): 58-67, 1996

      32 Lydiard RB, "Coexisting depression and anxiety: special diagnostic and treatment issues" 52 (52): 48-54, 1991

      33 Nordahl TE, "Cerebral glucose metabolic differences in patients with panic disorder" 3 (3): 261-272, 1990

      34 Eysenck MW, "Bias in interpretation of ambiguous sentences related to threat in anxiety" 100 (100): 144-150, 1991

      35 Hettema JM, "Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism" 11 (11): 752-762, 2006

      36 Jacobson NC, "Anxiety and depression as bidirectional risk factors for one another : A meta-analysis of longitudinal studies" 143 (143): 1155-1200, 2017

      37 Lepola U, "Alcohol and depression in panic disorder" 377 : 33-35, 1994

      38 Rorsman B, "A prospective study of first-incidence depression. The Lundby study, 1957–72" 156 (156): 336-342, 1990

      39 Hettema JM, "A population-based twin study of the relationship between neuroticism and internalizing disorders" 163 (163): 857-864, 2006

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 SCI 등재 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.48 0.37 1.06
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.85 0.75 0.691 0.11
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼